
Keywords: BCLC; Barcelona Clinical Liver Cancer; CLDN; claudin; CTC; circulating tumor cell; CSC; cancer stem cells; ECM; extracellular matrix; EGF; epidermal growth factor; EMT; epithelial to mesenchymal transition; FSP-1; fibroblast-specific protein; GANK; gankyr